Telura Tablet

Telura Tablet – Lamivudine (300mg) + Tenofovir disoproxil fumarate (300mg) + Efavirenz (600mg)

Telura Tablet is a once-daily fixed-dose combination of Lamivudine 300mg, Tenofovir Disoproxil Fumarate 300mg and Efavirenz 600mg, manufactured by Mylan Pharmaceuticals Pvt Ltd – A Viatris Company. The two NRTIs work alongside the NNRTI Efavirenz to block HIV replication at multiple stages, forming a complete single-tablet antiretroviral regimen.

Key Features

• Complete once-daily triple-drug ART regimen in a single tablet, made by Mylan (Viatris)
• Combines 2 NRTIs with the NNRTI Efavirenz
• Helps lower HIV viral load and supports CD4 recovery
• Simplifies adherence with one tablet, once daily
• Bottle of 30 tablets, Schedule H prescription drug

Composition

• Lamivudine (300mg) + Tenofovir disoproxil fumarate (300mg) + Efavirenz (600mg)

Uses & Benefits

• Used as complete first-line combination therapy for HIV-1 infection
• Helps reduce HIV viral load to undetectable levels over time
• Supports recovery and maintenance of CD4 cell counts
• Reduces the risk of HIV-related complications and opportunistic infections
• Simplifies long-term ART adherence with a single daily tablet
• Prescribed as part of a structured, physician-supervised regimen

Directions for Use

• Take exactly as prescribed by your physician
• Usually taken once daily at bedtime, on an empty stomach
• Taking at bedtime may help reduce Efavirenz-related dizziness or vivid dreams
• Do not miss doses – consistent adherence is critical for ART effectiveness

Precautions

• Use only under the supervision of a qualified physician
• Inform your doctor of any kidney or liver conditions before starting treatment
• Regular monitoring of blood counts, liver and kidney function may be required
• Inform your healthcare provider about all other medications you are taking
• Consult your doctor before use during pregnancy or breastfeeding
• Do not skip or stop doses without medical advice, as this may lead to drug resistance

Storage

• Store below 30°C in a cool, dry place
• Keep out of reach of children
• Protect from excessive heat and moisture

Disclaimer

This is a Schedule H prescription medicine. This information is for general awareness and is not a substitute for professional medical advice, diagnosis or treatment. Do not start, stop or change the dose without consulting a qualified healthcare provider.